KALA- Kala Bio, Inc.

Name: Kala Bio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kala Bio, Inc. (KALA) has 12 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. KALA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Iwicki Mark T	103.5K	$8.6K	-
10%	Baker Bros. Advisors LP	46.5K	$3.9K	-
Other	Kharabi Darius	41.8K	$3.5K	-
Other	Brazzell Romulus K	36.0K	$3.0K	-
Dir	Bazemore Todd	35.9K	$3.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2025	Iwicki Mark T71	Chief Executive Officer	Sell	5,779	$7.63	$44,093.77	-2.0%	-50.3%	-91.3%
Dec 30, 2024	Baker Bros. Advisors LP59	10% Owner	Buy	310,559	$6.44	$1,999,999.96	+34.8%	-16.6%	-91.8%
Jun 26, 2024	Bazemore Todd72	See Remarks	Sell	4,653	$4.75	$22,101.75	-5.3%	+20.0%	+14.2%
Jun 26, 2024	Kharabi Darius55	Chief Business Officer	Sell	5,158	$4.75	$24,500.50	-7.9%	+20.0%	+14.2%
Jun 26, 2024	Reumuth Mary71	Chief Financial Officer	Sell	4,163	$4.75	$19,774.25	-6.5%	+20.0%	+14.2%
Jun 26, 2024	Iwicki Mark T71	Chief Executive Officer	Sell	15,168	$4.75	$72,048.00	-5.4%	+20.0%	+14.2%
Jun 26, 2024	Brazzell Romulus K71	See Remarks	Sell	5,489	$4.75	$26,072.75	-6.1%	+20.0%	+14.2%
May 31, 2024	Bazemore Todd72	See Remarks	Sell	2,093	$6.09	$12,746.37	-2.3%	-12.4%	-44.6%
May 31, 2024	Kharabi Darius55	Chief Business Officer	Sell	231	$6.09	$1,406.79	-0.4%	-12.4%	-44.6%
May 31, 2024	Reumuth Mary71	Chief Financial Officer	Sell	1,786	$6.09	$10,876.74	-2.7%	-12.4%	-44.6%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC